Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients (pages 354–362)
YASUHIRO KAWAI, NAOYUKI MIYASHITA, TETSUYA YAMAGUCHI, AKI SAITOH, EISUKE KONDOH, HIROKI FUJIMOTO, HIDETO TERANISHI, MIKA INOUE, TOKIO WAKABAYASHI, HIROTO AKAIKE, SATOKO OGITA, KOZO KAWASAKI, KIHEI TERADA, FUMIO KISHI and KAZUNOBU OUCHI
Version of Record online: 24 JAN 2012 | DOI: 10.1111/j.1440-1843.2011.02102.x
There have been no studies evaluating the microbiological efficacy of macrolides in patients with macrolide-resistant (MR) Mycoplasma pneumoniae infections. This study showed that the microbiological and clinical efficacies of macrolides for treating patients with MR M. pneumoniae pneumonia were low.